United Kingdom Vitamin D Testing Market to be Dominated by Rickets Segment Through 2028
The increasing mergers and acquisitions
in the pharmaceutical industry, along with the growing awareness among
individuals regarding the management of chronic diseases caused by vitamin D
deficiency to drive the Vitamin D Testing Market in the United Kingdom.
According
to TechSci Research report, “United Kingdom Vitamin D Testing Market – By
Region, Competition Forecast & Opportunities, 2018-2028F, the United Kingdom Vitamin D
Testing Market is anticipated to register a high CAGR during the forecast
period. This can be ascribed to an increase in spending by people on vitamin D
testing.
The United Kingdom Vitamin D Testing Market is
projected to experience growth in the forecast period due to the increasing
partnerships and agreements between leading pharmaceutical companies. These
collaborations aim to combine expertise and address the prevalence of diseases
caused by vitamin D deficiency. For example, Protas, a UK-based independent
non-profit organization, has announced a strategic partnership with the French
pharmaceutical company Sanofi. Additionally, AstraZeneca, a multinational
pharmaceutical and biotechnology company, approached Gilead Sciences in 2020
for expanding their healthcare business, resulting in a significant merger.
The United Kingdom faces significant health
concerns related to diseases caused by vitamin D deficiency, such as rickets
and osteoporosis, affecting approximately 20% of the population. The rising
awareness towards health and increased healthcare expenditure have contributed
to the growth of the United Kingdom Vitamin D Testing Market. The population's
medical expenditure of around USD 279.34 billion annually has made healthcare
services, including doctor visits, diagnostic tests, medications, and
nutritional support, more accessible. The affordability of rapid vitamin D
testing kits has also led to regular monitoring of vitamin D levels among
individuals.
Furthermore, the growth of the geriatric population
and the prevalence of diseases such as Osteomalacia, Myopathy, and
Osteoporosis, which are caused by inadequate vitamin D intake, are driving
factors for the United Kingdom Vitamin D Testing Market in the forecast period.
According to an analysis published by Statista in 2021, the elderly population
in the United Kingdom represents a significant portion of the total population
across various age groups. Osteoporosis, in particular, is more prevalent among
older individuals in the United Kingdom, resulting in the deterioration of bone
tissues and increased bone fragility.
According
to the report published by International Longevity Center in 2018, it has been
observed that around 300,000 people in United Kingdom suffer from fragility fracture every year including
over 70,000 hip fractures. Indeed, approximately 1,150 people in the UK die due
to hip fractures per year. Therefore, the increase in demand for vitamin D testing for
prevention of such disorders are supporting the market growth.
However, high costs of sample collection and sample
processing for vitamin D testing and decline in number of routine vitamin D
tests in United Kingdom after the COVID-19 pandemic are expected to slow down
the growth of the market in the coming years.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
" United Kingdom Vitamin D Testing Market.”
The segmentation of the United Kingdom Vitamin D
Testing Market is based on Product, Technology, Indication, End User, Region
and Competitive Landscape. In terms of indication, the market is further
divided into Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D
Deficiency, and Others. The rickets segment is expected to have a dominant
presence in the market during the forecast period. This can be attributed to
its prevalence among the people of the United Kingdom, particularly children,
which has significant impacts on their lifestyle.
Some of the key companies operating in the United
Kingdom Vitamin D Testing Market include:
- F. Hoffmann-La Roche Ltd.
- Abbott
Laboratories Ltd.
- Quest
Diagnostics Incorporated
- bioMerieux
UK Ltd.
- Diasorin
Ltd.
- Thermo
Fisher Scientific Inc.
- Beckman
Coulter United Kingdom Ltd.
- Tosoh
Bioscience Limited
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“Certain regions such as London are
expected to dominate the demand for Vitamin D Testing in
United Kingdom. The presence of leading
pharmaceutical companies in the market, dedicated to enhancing productivity
through the incorporation of specific properties in their vitamin D testing
kits, such as reference ranges and standardized units of measurement, is
expected to drive significant growth in the United Kingdom Vitamin D Testing
Market during the forecast period.," said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based Global management consulting
firm.
United Kingdom Vitamin D Testing Market By Product (25-Hydroxy
Vitamin D Test, 1,25-Dihydroxy Vitamin D Test), By Technology (Radioimmunoassay, ELISA, HPLC, LC-MS, Others), By
Indication (Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D
Deficiency, Others), By End User (Diagnostic Laboratories, Hospitals and
Clinics, Homecare, Others), By Region, Competition Forecast &
Opportunities, 2018-2028F”,
has evaluated the future growth potential of United Kingdom Vitamin D Testing Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the United Kingdom Vitamin D Testing Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com